BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 34572302)

  • 1. Adeno-associated virus-mediated expression of activated factor V (FVa) for hemophilia phenotypic correction.
    Sun J; Chen X; Chai Z; Niu H; Dobbins AL; Nichols TC; Li C
    Front Med (Lausanne); 2022; 9():880763. PubMed ID: 35991645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma.
    Kapelanski-Lamoureux A; Chen Z; Gao ZH; Deng R; Lazaris A; Lebeaupin C; Giles L; Malhotra J; Yong J; Zou C; de Jong YP; Metrakos P; Herzog RW; Kaufman RJ
    Mol Ther; 2022 Dec; 30(12):3542-3551. PubMed ID: 36242517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of long-term tolerance to a specific antigen using anti-CD3 lipid nanoparticles following gene therapy.
    Chen CY; Vander Kooi A; Cavedon A; Cai X; Hoggatt J; Martini PGV; Miao CH
    Mol Ther Nucleic Acids; 2023 Dec; 34():102043. PubMed ID: 37920545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophilia A: an ideal disease to correct in utero.
    Porada CD; Rodman C; Ignacio G; Atala A; Almeida-Porada G
    Front Pharmacol; 2014; 5():276. PubMed ID: 25566073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of statin intake on FVIII levels and bleeding outcomes in hypercholesterolemic patients with hemophilia A.
    Paciullo F; Momi S; Mancuso ME; Santoro C; Napolitano M; Castaman G; Zanon E; Contino L; De Cristofaro R; Santoro RC; Gresele P
    Thromb Res; 2024 Apr; 236():167-169. PubMed ID: 38457995
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombosis and novel hemophilia therapies: the fine line between clotting and bleeding.
    Hoffman M
    Blood Adv; 2021 Sep; 5(18):3736. PubMed ID: 34581771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of alternative gene transfer techniques for
    Noda M; Tatsumi K; Matsui H; Matsunari Y; Sato T; Fukuoka Y; Hotta A; Okano T; Kichikawa K; Sugimoto M; Shima M; Nishio K
    Regen Ther; 2021 Dec; 18():347-354. PubMed ID: 34584911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Utero Cell Treatment of Hemophilia A Mice via Human Amniotic Fluid Mesenchymal Stromal Cell Engraftment.
    Kao YT; Yen CC; Fan HC; Chen JK; Chen MS; Lan YW; Yang SH; Chen CM
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-viral and viral delivery systems for hemophilia A therapy: recent development and prospects.
    Zangi AR; Amiri A; Pazooki P; Soltanmohammadi F; Hamishehkar H; Javadzadeh Y
    Ann Hematol; 2024 May; 103(5):1493-1511. PubMed ID: 37951852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability of the Thrombin Generation Test to Evaluate the Hemostatic Status of Hemophilia A Patients in Daily Clinical Practice.
    Bernardo Á; Caro A; Martínez-Carballeira D; Corte JR; Vázquez S; Palomo-Antequera C; Andreu A; Fernández-Pardo Á; Oto J; Gutiérrez L; Soto I; Medina P
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIII.
    Zollner SB; Raquet E; Müller-Cohrs J; Metzner HJ; Weimer T; Pragst I; Dickneite G; Schulte S
    Thromb Res; 2013 Aug; 132(2):280-7. PubMed ID: 23830969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophilia A gene therapy via intraosseous delivery of factor VIII-lentiviral vectors.
    Miao CH
    Thromb J; 2016; 14(Suppl 1):41. PubMed ID: 27766066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical gene transfer studies for hemophilia A.
    Chuah MK; Collen D; VandenDriessche T
    Semin Thromb Hemost; 2004 Apr; 30(2):249-56. PubMed ID: 15118936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Coagulation Factor VIII Gene Therapy in a Mouse Model of Hemophilia A by Lipid-Coated Fe
    Kao YT; Chen YT; Fan HC; Tsai TC; Cheng SN; Lai PS; Chen JK; Chen CM
    Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system.
    Ohlfest JR; Frandsen JL; Fritz S; Lobitz PD; Perkinson SG; Clark KJ; Nelsestuen G; Key NS; McIvor RS; Hackett PB; Largaespada DA
    Blood; 2005 Apr; 105(7):2691-8. PubMed ID: 15576475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Therapy with BMN 270 Results in Therapeutic Levels of FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice.
    Bunting S; Zhang L; Xie L; Bullens S; Mahimkar R; Fong S; Sandza K; Harmon D; Yates B; Handyside B; Sihn CR; Galicia N; Tsuruda L; O'Neill CA; Bagri A; Colosi P; Long S; Vehar G; Carter B
    Mol Ther; 2018 Feb; 26(2):496-509. PubMed ID: 29292164
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.